SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-22-112034
Filing Date
2022-10-27
Accepted
2022-10-27 16:47:08
Documents
2
Group Members
DR. SENAI ASEFAWPARADIGM BIOCAPITAL ADVISORS GP LLCPARADIGM BIOCAPITAL INTERNATIONAL FUND LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2229071d1_sc13g.htm SC 13G 63533
2 EXHIBIT 1 tm2229071d1_ex1.htm EX-99.1 3751
  Complete submission text file 0001104659-22-112034.txt   68946
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Subject) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92269 | Film No.: 221337904
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017 646-970-2123
Paradigm Biocapital Advisors LP (Filed by) CIK: 0001855655 (see all company filings)

IRS No.: 851451055 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G